Lawyers in our firm’s Mass Torts Section are pleased to report that after years of litigation involving Bayer’s drosperinone-containing oral contraceptives, including Yaz, Yasmin, Ocella, Gi... Read more
We have again been asked to give an update on current activities in our firm’s Mass Torts Section. Lawyers in the Section have been very busy and are handling cases in several states in both... Read more
Bayer AG’s 2012 year-end annual report contains some interesting information on the litigation involving Yaz and Yasmin. The company’s released numbers have made it clear that the German AG... Read more
More Yasmin birth control lawsuits have been filed against Bayer, alleging the contraception is linked to serious side effects. Bayer has put money aside to settle Yasmin and Yaz side effect... Read more
Bayer could pay more than $1.2 billion to settle personal injury lawsuits over the company’s Yaz and Yasmin birth control pills, according to a recent stock filing. As part of its second qua... Read more
Bayer has agreed to settle about 70 of the approximately 11,300 product liability claims involving the oral contraceptives Yaz and Yasmin, according to the drug company’s latest annual repor... Read more
An independent watchdog group has asked the Food and Drug Administration to disregard a safety panel’s recommendation to keep the popular birth control drugs Yaz and Yasmin on the market. Ev... Read more
The FDA Reproductive Health Drugs Advisory Committee, on December 8, 2011, overwhelmingly concluded that Bayer should warn that users of its 4th generation, drosperinone-containing oral birt... Read more
A new study, released by the US Food and Drug Administration, reviewed the medical history of more than 800,000 women who were taking different forms of birth control between 2001 and 2007.... Read more
U.S. District Court Judge David R. Herndon, the federal judge presiding over Yasmin and Yaz multidistrict litigation, is formulating a plan which he believes will help the parties reach a se... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.